SCHEMBL684944

SCHEMBL684944

Cc1ccc(C(=O)N/N=C/c2cc(Br)ccc2O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASF1A Q9Y294 2/20 0.74
PIK3CG P48736 1/20 0.73
KMT2A Q03164 9/20 0.73
KDM4E B2RXH2 7/20 0.73
MAPT P10636 6/20 0.73
RAB9A P51151 5/20 0.73
MEN1 O00255 5/20 0.73
MITF O75030 4/20 0.73
NPC1 O15118 3/20 0.73
TDP1 Q9NUW8 1/20 0.73
L3MBTL1 Q9Y468 1/20 0.73
KLF5 Q13887 2/20 0.72
HTT P42858 5/20 0.69
LMNA P02545 3/20 0.69
SMN1; SMN2 Q16637 3/20 0.69
POLB P06746 2/20 0.69
PSMD14 O00487 1/20 0.69
MMP2 P08253 1/20 0.69
BLM P54132 1/20 0.69
SIRT1 Q96EB6 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26974369 0.92 RAB9A (0.73) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL685183 0.90 PIK3CG (0.70) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL19283338 0.89 KMT2A (0.76) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL19283336 0.89 KMT2A (0.76) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL685060 0.89 MAPT (0.72) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL30122159 0.87 KMT2A (0.85) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL684525 0.87 KMT2A (0.85) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL20446303 0.87 KMT2A (0.85) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL684930 0.86 KMT2A (0.76) ASF1APIK3CGKMT2AKDM4EMAPT
SCHEMBL20587552 0.85 KMT2A (0.74) ASF1APIK3CGKMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-01-02 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010075-A1 SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, SOD3 ASF1A 1869/4885PIK3CG 2876/4885KMT2A 1362/4885
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, DPM1 ASF1A 2765/4885PIK3CG 488/4885KMT2A 3071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.